FDA revises monitoring for SCLC therapy Initial monitoring decreases from 22 to 24 hours to 6 to 8 hours from the start of the first 2 infusions. By Kathryn Wighton September 15, 2026 2 min MDSpire News Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Topic Commentary
